Access to medicines
HSRC REPORT: This paper discusses the value-added of Advance Purchase Commitments, how they could be used alongside other incentives and investment approaches and the potential impact they might have on different types of product, stages of product development and types of firms, especially regarding health technologies in poor countries.It also highlights the different taxonomies used… Read more
HSRC REPORT:This paper is an introduction to the key issues and debates in access to medicines (ATM) and drug regulation in developing countries. It outlines the current debates in ATM and regulation as well as providing details of the evidence base, including detailed references of studies and papers which have focused on specific issues and… Read more
HSRC REPORT: This briefing paper documents a variety of technology transfer experiences in the pharmaceutical sector between developing and developed countries and analyses the motivations behind these agreements.
HSRC REPORT: This study extrapolates empirical cost data from Sub-saharan African firms to consider the conditions under which domestic production of drugs in a facility in Sub-saharan Africa would be feasible and profitable as a business enterprise, while at the same time, able to promote better access to quality medicines, at a price more affordable… Read more
HSRC REPORT: An overview paper of seven new studies commissioned by the Access to Medicines team at the Department for International Development which focused on issues of current concern and debate in developing countries. The paper also explores issues related to international trade, intellectual property and drug registration requirements. It explores how these policy trends… Read more
HSRC REPORT: This study describes the current context relating to access to medicines in Kenya , which currently obtains medicines from domestic and international sources. It also outlines the influence of TRIPS on availability of essential medicines in health centers in Kenya. It looks at how TRIPS flexibilities influence the importation of specific drugs and… Read more
HSRC REPORT: This study describes the current context relating to access to medicines in Malawi, including sources of supply and relevant existing legislation. It outlines future access scenarios, and suggests that current political will be capitalised upon and key ministries and institutions be supported in their access to medicines-related and broader TRIPs-related initiatives.
HSRC REPORT: This paper addresses varied ways by which a non-producing country may lawfully utilise TRIPS flexibilities, and looks at the internal and external forces which negatively affect non-producing countries’ ability and willingness to use TRIPS-compliant flexibilities.
HSRC REPORT: This study considers: how is the implementation of product patents in India and China affecting access to medicines; will generic copies of patented medicines have to be withdrawn from the market; will prices rise; will the domestic industry disappear; and will MNCs (Multi-national Corporations) become more interested in working with domestic firms, including… Read more
HSRC REPORT: This study describes current drug regulation and registration processes in selected countries in order to understand how they affect the quality and availability of medicines in developing countries, develops policy recommendations as to how systems can more efficiently allow appropriate quality drugs to market, and discusses emerging challenges and requirements posed by compulsory… Read more
HSRC REPORT: This paper aims to increase understanding of the requirements for introducing and scaling up provision of Anti-retroviral Therapy (ART) as part of comprehensive HIV/AIDS programmes in resource-poor countries. It explores the feasibility of ART in resource poor settings;the different approaches taken to the delievery of ART; the issues to be considered in scaling… Read more